Equity Incentive Plan (Details Narrative) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2023 |
Dec. 31, 2022 |
Jan. 01, 2022 |
|
| Common stock, authorized | 250,000,000 | 250,000,000 | |
| 2021 Omnibus Equity Incentive Plan [Member] | |||
| Weighted-Average Recognized Remaining Contractual Term (in Years) | 2 years 3 months 18 days | ||
| Additional shares reserved for future issuance | 127 | 5,205 | |
| Stock awards granted, exercisable period | 10 years | ||
| Unrecognized stock based compensation expense | $ 1.0 | ||
| Common stock, authorized | 7,701 | ||
| Stock awards granted, vesting period | four years for employees and one year for directors of the Company’s board and consultants | ||
| Common stock traded price | $ 1.29 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|